Download Medical Notes on Evaluate Vantage Pharma, Biotech and Medtech Half-Year Review 2020

Evaluate Vantage Pharma, Biotech and Medtech Half-Year Review 2020 Medical Notes

About This Presentation

Description:The coronavirus pandemic has been the driving force shaping the biopharma and medtech sectors over the first half of 2020. And, while much of the fallout has been predictable, certain events and trends have surprised. Check out the Evaluate Vantage Pharma, Biotech and Medtech Half-Year Review 2020 for more details

Tags:Pharma, Biotech, Medtech Half-Year Review, 2020 , coronavirus, pandemic

Published on: Jul 30, 2020 | Views : 1602 | Downloads : 0

Comment

Transcript

No transcript available for this presentation

User Presentation
Related Presentations

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2019 - Booklet 3

By: MattB
Views: 1247

The Pharmaceutical Industry and The Process of Drug Discovery

By: MattB
Views: 1242

Deloitte's 2019 Global health care outlook

By: MattB
Views: 1220

Cancer Medicines: Value in Context

By: MattB
Views: 1910

Taming big Pharma

By: MattB
Views: 1181

Pharma 2020 Marketing the future - a paper on the future of the pharmaceutical industry

By: KhushbuSG
Views: 1088

2020 US and global life sciences outlook

By: MattB
Views: 1262

Hospital Pharmacy Compliance Handbook

By: anupma
Views: 1091

Evaluate Vantage Pharma, Biotech & Medtech Half-Year Review 2019

By: MattB
Views: 1090

Diabetes Costs and Affordability in the United States

By: docshare
Views: 1064

MattB

About : An experienced pharma professional managing sales, marketing and brand management of top global pharma products Presently leading a team of experts in the development and execution of pharma eCommerce strategies that support GSK products to HCP customers.
Occupation : Medical Professional
Specialty : Other Health Professionals
Country : United States of America
Website :

HEALTH A TO Z